Intrathecal Contrast-Enhanced Magnetic Resonance Imaging-Related Brain Signal Changes: Residual Gadolinium Deposition?

Investigative Radiology

Volumn 52, Issue 4, 2017, Pages 195-197

  Öner, Ali Yusuf ^a   Barutcu, Berrak ^a   Aykol, Şükrü ^a   Tali, Emin Turgut ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Brain; gadolinium; glymphatic system; intrathecal; MRI

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADOLESCENT; ADULT; AGED; ARACHNOID CYST; ARTICLE; CEREBROSPINAL FLUID RHINORRHEA; CISTERNOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; GLOBUS PALLIDUS; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; BRAIN; DIAGNOSTIC IMAGING; DRUG EFFECTS; IMAGE ENHANCEMENT; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRAIN; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84991497577     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0000000000000327     Document Type: Article

References (27)

1. Kanda T, Ishii K, Kawaguchi H, et al. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology. 2014;270:834-841.
2. Kanda T, Fukusato T, Matsuda M, et al. Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology. 2015;276:228-232.
3. Kanda T, Matsuda M, Oba H, et al. Gadolinium deposition after contrastenhanced MR imaging. Radiology. 2015;277:924-925.
4. Kanda T, Oba H, Toyoda K, et al. Brain gadolinium deposition after administration of gadolinium-based contrast agents. Jpn J Radiol. 2016;34:3-9.
5. McDonald RJ, McDonald JS, Kallmes DF, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology. 2015;275:772-782.
6. Kanda T, Osawa M, Oba H, et al. High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology. 2015;275:803-809.
7. Radbruch A, Weberling LD, Kieslich PJ, et al. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology. 2015;275:783-791.
8. Ramalho J, CastilloM, AlObaidy M, et al. High signal intensity in globus pallidus and dentate nucleus on unenhanced T1-weighted MR images: evaluation of two linear gadolinium-based contrast agents. Radiology. 2015;276:836-844.
9. Cao Y, Huang DQ, Shih G, et al. Signal change in the dentate nucleus on T1-weighted MR images after multiple administrations of gadopentetate dimeglumine versus gadobutrol. Am J Roentgenol. 2016;206:414-419.
10. Radbruch A, Weberling LD, Kieslich PJ, et al. High-signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evaluation of the macrocyclic gadolinium-based contrast agent gadobutrol. Invest Radiol. 2015;50:805-810.
11. Runge VM. Safety of the gadolinium-based contrast agents for magnetic resonance imaging, focusing in part on their accumulation in the brain and especially the dentate nucleus. Invest Radiol. 2016;51:273-279.
12. Iliff JJ, Lee H, Yu M, et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest. 2013;123:1299-1309.
13. Bleicher AG, Kanal E. Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23, 553 administrations of gadobenate dimeglumine. AJR Am J Roentgenol. 2008;191:W307-W311.
14. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis Nephrol Dial Transplant. 2006;21:1104-1108.
15. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am SocNephrol. 2006;17:2359-2362.
16. Kanal E, Tweedle MF. Residual or retained gadolinium: practical implications for radiologists and our patients. Radiology. 2015;275(3):630-634.
17. Jost G, Lenhard DC, Sieber MA, et al. Signal Increase on unenhanced T1-weighted images in the rat brain after repeated, extended doses of gadoliniumbased contrast agents: comparison of linear andmacrocyclic agents. Invest Radiol. 2016;51(2):83.
18. Cao Y, Zhang Y, Shih G, et al. Effect of renal function on gadolinium-related signal increases on unenhanced T1-weighted brain magnetic resonance imaging. Invest Radiol. 2016.
19. Errante Y, Cirimele V, Mallio CA, et al. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patientswith normal renal function, suggesting dechelation. Invest Radiol. 2014;49:685-690.
20. Tali ET, Ercan N, Krumina G, et al. Intrathecal gadolinium (gadopentetate dimeglumine) enhanced magnetic resonance myelography and cisternography: results of a multicenter study. Invest Radiol. 2002;37:152-159.
21. Tali ET, Ercan N, Kaymaz M, et al. Intrathecal gadolinium (gadopentetate dimeglumine)-enhanced MR cisternography used to determine potential communication between the cerebrospinal fluid pathways and intracranial arachnoid cysts. Neuroradiology. 2004;46:744-754.
22. EcinG, OnerAY, TokgozN, et al. T2-weighted vs. intrathecal contrast-enhancedMR cisternography in the evaluation of CSF rhinorrhea. ActaRadiol. 2013;54:698-701.
23. Yang L, Kress BT, Weber HJ, et al. Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer. J TranslMed. 2013;11:107.
24. Eide PK, Ringstad G. MRI with intrathecal MRI gadolinium contrast medium administration: a possible method to assess glymphatic function in human brain. ActaRadiol Open. 2015;4:2058460115609635.
25. Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. SciTransl Med. 2012;4:147ra11.
26. Brown PD, Davies SL, Speake T, et al. Molecular mechanisms of cerebrospinal fluid production. Neuroscience. 2004;129:957-970.
27. Praetorius J. Water and solute secretion by the choroid plexus. Pflugers Arch. 2007;454:1-18.